 |
CX 2021 has finished but that does not mean you have missed your opportunity to view all the high-quality content that was on display. All our sessions, from both Livestream 1 and Livestream 2, are available on-demand on our dedicated CX 2021 channel.
To get access to the entire content from […]
CX 2021 has finished but that does not mean you have missed your opportunity to view all the high-quality content that was on display. All our sessions, from both Livestream 1 and Livestream 2, are available on-demand on our dedicated CX 2021 channel.
To get access to the entire content from […]
Barbara Rantner (Munich, Germany; CX Executive Board Member) discusses some of the upcoming highlights from the session including an array of debates which are outlined below and which Rantner notes “really matter to the global vascular community”.
You can register for CX 2021 here.
Christopher Aylwin (UK) talks about resuscitative endovascular balloon occlusion of the aorta (REBOA), which he notes will likely be the biggest controversial topic in this year’s Vascular […]
“International practice differences exist in cannulation and dialysis provision with some approaches aiming for fistulas to suit the logistics of dialysis, rather than best long-term outcomes for the fistula and the patient”
The CX 2021 Vascular Access Controversies Programme is designed to showcase the latest advances and disputes […]
William Jeffcoate (UK) discusses his upcoming presentation at the Hurting Leg session at CX 2021, titled The impact of socio-economic and clinical variables on the incidence of major amputation in people with diabetic foot ulcers.
The session, which will take place on Thursday 22 April, will shine a […]
Lowell Kabnick (USA) talks about what he is looking forward to in the upcoming Venous & Lymphatic Controversies (Superficial) session at CX 2021. He also discusses his own presentation, Is there evidence to justify an aggressive strategy for the ablation of incompetent perforators?. This controversial topic is “important to the […]
Colin Bicknell (UK) and Michael Jenkins (UK) will go toe-to-toe in a hotly anticipated debate at CX 2021 titled Standard EVAR can be used in most challenging necks. Bicknell will be arguing for the motion and Jenkins–who is current president of the Vascular Society of Great Britain and Ireland (VSGBI)–will be […]
Andrew Holden (New Zealand; CX Executive Board Member) discusses some of the main features of the upcoming Peripheral Proximal session at CX 2021 as well as his Podium 1st presentation–Five-year meta-analysis including mortality update with FDA-approved RCTs of paclitaxel devices.
You can register for CX 2021 here. […]
Re-live the inaugural CX Aortic Vienna with our complimentary on-demand offering, giving you access to the latest in aortic research and debate from world-leading experts.
This exclusive, one-off opportunity allows you to access every session from CX Aortic Vienna 2020, including the presentations, discussion, audience participation and polling.
CX Aortic Vienna broadcast […]
| Roberto Chiesa (Milan, Italy) talks about the importance of his practical HOW TO DO IT (HDTI) approach, the philosophy of which he will bring to the inaugural CX Aortic Vienna and will manifest through a range of “practical videos” showing the “most modern […] |
Alexander Zimmermann (Zürich, Switzerland) and Afshin Assadian (Vienna, Austria) talk about the “long tradition of cooperation” between the Austrian Society for Vascular Surgery (ÖGG) and the Swiss Society for Vascular Surgery (SGG), who will hold two joint sessions at the inaugural CX Aortic Vienna.
Zimmermann believes it is a […]
Maarit Venermo (Helsinki, Finland) talks about how CX Aortic Vienna will offer “high quality education” to people treating aortic diseases, and discusses her presentation at this inaugural event, titled ‘Ultrasound surveillance versus CT surveillance after EVAR’.
CX Aortic Vienna, which will be livestreamed on 8, 9, 10 and 11 September […]
The inaugural CX Aortic Vienna, to be livestreamed on 8, 9, 10 and 11 September 2020 with audience participation, discussion and polling, has been accredited with 12 EU/US reciprocal CME credits.
Accreditation Statement
The CX Aortic Vienna 2020, London (live streaming), United Kingdom, 08/09/2020-11/09/2020 has been accredited […]
Clockwise from top left: Roger Greenhalgh (London, UK), Stéphan Haulon (Paris, France), Gustavo Oderich (Rochester, USA), Nikolaos Tsilimparis (Munich, Germany), Bijan Modarai (London, UK) and Said Abisi (London, UK). Click on the image to watch the Juxtarenal Aneursym Consesus session on demand.
During […]
Clockwise from top left: Roger Greenhalgh (London, UK), Gustavo Oderich (Rochester, USA), Roberto Chiesa (Milan, Italy), Eric Verhoeven (Nuremberg, Germany), Frank Arko (Charlotte, USA), and Tilo Kölbel (Hamburg, Germany). Click on the image to watch the Aortic Podium 1st Session on demand.
Roberto Chiesa (Milan, Italy) invites you to the CX 2020 LIVE Aortic Podium 1st Session which will feature abdominal aortic and thoracic aortic presentations and discussion from specialists in the field, including Tilo Kölbel, Frank Arko, Eric Verhoeven, Stephan Haulon, Giovanni Torsello and Fabio Verzini.
The session, which begins on […]
CX 2020 LIVE’s Vascular Access Consensus panel, including (clockwise from top left): Roger Greenhalgh (London, UK), Nick Inston (Birmingham, UK), Domenico Valenti (London, UK), Robert Jones (Birmingham, UK), Robert Shahverdyan (Hamburg, Germany) and Jennifer Hanko (Belfast, UK). Click […]
Armando Mansilha (Porto, Portugal), who is also a member of the CX Venous Executive Board, welcomes you to the Deep Venous Disease Consensus session at CX 2020 LIVE. Deep venous disease is a “significant medical problem for patients” and also a “substantial burden for our healthcare systems”, notes Mansilha.
In […]
Ali Azizzadeh (top) chaired the CX 2020 LIVE Industry Symposium, which featured contributions from Hence Verghagen (bottom row left), Richard Gibbs (bottom row left), and Santi Trimarchi (bottom row right)
Benefits of using angulation control in thoracic endovascular aortic repair (TEVAR), an update […]
Data from three global, real-world registries, GREAT, ExCeL and BSET-CLEVAR, evaluating the Excluder Conformable abdominal aortic aneurysm (AAA) Endoprosthesis with Active Control System, were shared online during the CX 2020 LIVE virtual, vascular conference. Broadcast to a global audience at the conclusion of the second […]
CX 2020 LIVE will consist of 10 live sessions, which will feature audience participation, and run from 16:00 BST/11:00 EDT/17:00 CEST every Tuesday and Thursday, from 26 May until 25 June. Make sure you register now to participate in the CX 2020 LIVE sessions.
Nicholas Inston (Birmingham, UK), co-chair of the Vascular […]
Manj Gohel (Cambridge, UK), who is also a member of the CX Venous Executive Board, welcomes you to CX 2020 LIVE, which will include some of the major highlights from the deep and superficial venous programmes.
A number of recently released “important guidelines” in the superficial venous space will be presented […]
World-leading vascular surgeon, Stéphan Haulon (Paris, France), who is also a member of the CX Aortic Executive Board, extols the “high-quality” digital educational programme of CX 2020 LIVE and highlights the “very exciting” thoracic aortic and abdominal aortic consensus sessions that will be chaired by a host of other experts […]
Roberto Chiesa (Milan, Italy), who was at the frontline of the COVID-19 pandemic in the Lombardy region of Italy, shares his team’s experience in tackling vascular and aortic emergencies during this time.
Chiesa outlines the response in the region to the pandemic, including the creation of new intensive care units (ICUs) […]
Join a wealth of experts and faculty from around the world for the very first session of CX 2020 LIVE—the inaugural virtual Charing Cross (CX) Symposium—titled ‘Paclitaxel-coated Device Consensus Update’.
Renowned interventional radiologist Andrew Holden (Auckland, New Zealand), who is a member of the CX Peripheral Arterial Executive Board, welcomes the […]
The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed and timely vascular and endovascular education virtual event: CX 2020 LIVE. Mark your calendars for this live digital experience, designed to deliver high-quality vascular education and featuring […]
Sophie Renton (London, UK) moderates a session with Michel Makaroun (Pittsburgh, USA) and Armando Mansilha (Porto, Portugal) where the trio discuss some of the challenges relating to recruitment within the field of vascular surgery.
Makaroun explains that there are two main recruitment pathways into vascular surgery in the USA but notes […]
Kevin Mani (Uppsala, Sweden) chats to BLearning about the upcoming Aortic Workshop at CX 2020 (Charing Cross Symposium; 21–24 April, London, UK), noting how the sessions will give attendees access to experts, the latest technologies and provide a platform for hands-on experience with new devices and imaging technology.
Workshop participants can take this […]
Roger Greenhalgh (London, UK) speaks to former president of the SVS (2018–2019) Michel Makaroun (Pittsburgh, USA) about the CX Symposium which Makaroun says “always has a special flavour” and is “a special meeting”. Makaroun also touches on some of the similarities and differences between CX and the SVS meeting in […]
Roger Greenhalgh (London, UK) and W L Gore’s Michael Koenke (Flagstaff, USA), take a look back at the history of the Charing Cross Symposium (CX), which began in 1978.
Koenke says that CX is a “special meeting for us”, adding that it is an “opportunity for us to connect with our […]
Roger Greenhalgh (London, UK) chats with Enrico Ascher (New York, USA) about some of the highlights of the CX Symposium, how it differs to the VEITH symposium in the USA and also how the two complement each other.
Ascher says he is always “totally amazed by the scientific level” of CX, […]
Alberto Muñoz (Bogota, Colombia) talks to BLearning at CX 2019 (Charing Cross Symposium; 15–18 April, London, UK) about how the meeting provides a “great opportunity” to update attendees on the latest in vascular and endovascular surgery.
Muñoz goes on to highlight the international flavour of Charing Cross and notes the importance of the […]
Roger Greenhalgh (London, UK) is joined by Fiona Rohlffs (Hamburg, Germany), Tilo Kölbel (Hamburg, Germany) and Heinz Jakob (Essen, Germany) to discuss the latest findings of the Stroke from Thoracic Endovascular Procedures (STEP) study which were presented at CX 2019 (Charing Cross Symposium; 15–18 April 2019, London, UK). […]
Leading experts including Robert Morgan (London, UK), Richard McWilliams (Liverpool, UK), Stéphan Haulon (Paris, France), Tilo Kölbel (Hamburg, Germany) and Peter Schneider (Honolulu, USA) discuss the various approaches to correcting endoleak during CX 2018 (Charing Cross Symposium; 24–27 April 2018; London, UK).
Giovanni Torsello (Münster, Germany) and Mauro Gargiulo (Bologna, Italy) discuss the “very high” morbidity and mortality caused by open surgery when treating complex aortic aneurysms. This is […]
Speaking at the Charing Cross Symposium 2019, Jeffrey Jump (Nyon, Switzerland), outlines the impact of the Medical Device Regulations (MDR), which he believes will be “the most devastating thing to happen to European healthcare in Europe since World War Two”.
Patients “will bear the brunt of this hardship” says Jump, who […]
Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular Lithotripsy (IVL; Shockwave) in the treatment of calcified arteries beyond the […]
Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.
Hayes talks about the accuracy of the device’s deployment around the thoracic […]
Andrew Holden (Auckland, New Zealand) and Peter Schneider (San Francisco, USA) discuss the Tack Endovascular System (Intact Vascular) and its impact on below the knee and above the knee procedures at the Charing Cross Symposium 2019. Schneider talks about the “limitations of the current clunky stenting paradigm” and how the […]
A CX 2019 special session highlighted the durability of endovascular aneurysm repair (EVAR) and the implications of the UK National Institute for Health and Care Excellence (NICE) draft aortic aneurysm guidelines. The final publication of these guidelines has been postponed on numerous occasions.
Opening the session, Stéphan Haulon and his team […]
Roger Greenhalgh (London, UK) interviewed Fiona Rohlffs (Hamburg, Germany), Maarit Venermo (Helsinki, Finland) and David Epstein (Granada, Spain) at the CX Live studio after their ‘Optimising surveillance and reintervention strategy following elective EVAR’ session.
Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]
Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]
Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.
Edmonds discusses why “too many legs are being lost” and Serena talks […]
Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.”
Hiramoto is presenting new research on this topic at the Charing Cross session on Spinal Cord Ischaemia in the Upper […]
Jonathan Beard, (Sheffield, UK), discusses the current medicolegal issues in the field and explains how vascular surgeons can become “the fall-guy for the inadequacies of other clinicians”. Beard touches on how the threshold for informed consent has changed “dramatically” in recent years which has led to “the death of […]
At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the value of paclitaxel devices in the treatment of peripheral arterial disease patients; examines new evidence on […]
There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices.
Cook Medical has just announced the release of de-identifiable […]
Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality signal raised by the Katsanos et al meta-analysis.
Ladich believes that “we need to take a step […]
In the Acute Stroke Challenges session on Monday, Nick Hopkins talks to CX Live about the “significant increase” of incidents of stroke following cardiac surgery which is “much more common than previously thought”.
Ross Naylor and Peter Schneider debated the impact of new technologies and innovations making carotid artery stenting as […]